A significant shift is underway in small-molecule drug discovery, as a new collaboration between Ginkgo Datapoints, Tangible Scientific, and Inductive…
Read More
SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch
The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…
Read More
Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth
This strategic collaboration, formally announced in early 2024, unites two powerhouses in healthcare: Labcorp, a global leader in clinical laboratory…
Read More
CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership
One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…
Read More
Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth
The diagnostic landscape for pediatric patients is poised for significant transformation following the announcement of a strategic collaboration between Labcorp,…
Read More
Biotechniques and Sartorius Launch Critical Survey to Map Cell Line Development Technologies and Challenges
BioTechniques, a leading scientific publication, in collaboration with Sartorius, a prominent international partner of the life science research and biopharmaceutical…
Read More
Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth
This strategic collaboration, officially announced by the two institutions, marks a significant development in the landscape of pediatric healthcare, aiming…
Read More
Kaggle and Google Launch Free Generative AI Course, Setting World Record for Virtual AI Education
In a significant move to democratize access to cutting-edge artificial intelligence education, Google and Kaggle have collaborated to offer a…
Read More
Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109
Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…
Read MoreYOU MAY HAVE MISSED
